ENTEROL

Medicinal product

(Invented) name

ENTEROL

Active substance (s)

Liofilizuotos Saccharomyces boulardii CNCM I-745 ląstelės

Strength

250 mg

Pharmaceutical form

milteliai geriamajai suspensijai

Route (s) of administration

vartoti per burną

Legal status for supply

Nereceptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

A07FA02, Saccharomyces boulardii

Marketing authorisation holder

UAB Niromed, Lietuva

Date of authorisation

2026-04-14

Date of renewal

Documents

3309_3310_ENTEROL_milt_ger_susp_kaps_PZ_2026-04-14.docx

3309_3310_ENTEROL_milt_ger_susp_kaps_PL_2026-04-14.docx

Stage

Registruotas

Controlled?

No

Controlled substance type

Legal basis

Procedure number

Marketing authorisation procedure

Lygiagretus importas

Qualitative and quantitative composition

Paketėlyje yra	1 vnt.
Liofilizuotos Saccharomyces boulardii CNCM I-745 ląstelės	250 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
120499	106603	1106603	paketėlis	N10		Nereceptinis	LT/L/26/3309/001	Netiekiama	-	-	No	-	-	Download
120500	106604	1106604	paketėlis	N20		Nereceptinis	LT/L/26/3309/002	Netiekiama	-	-	No	-	-

Stadijos

Data	Stadija
2026-04-14	Registruotas